News

Probiotics were favored over placebo for CDI prevention, particularly with twice-daily dosing, but their overall effect on disease incidence was not significant.
Diet-related cancer risk awareness or behaviors are similar between cancer survivors and those without cancer.
The EPA’s proposal would rescind the EPA's ability to regulate greenhouse gases as pollutants, leading to wide deregulation.
The FDA has approved Sephience for the treatment of HPA in adult and pediatric patients 1 month of age and older with sepiapterin-responsive PKU.
The US Senate voted to confirm Dr Susan Monarez as the director of the CDC after her serving as the acting director.
The FDA has granted Priority Review to durvalumab for the treatment of resectable, early-stage and locally advanced (Stage II-IVA) gastric and gastroesophageal junction cancers.
Mild and moderate infections are common among individuals with IBD and tend to be linked to patient characteristics and treatments.
Upadacitinib is efficacious for achieving and sustaining endoscopic remission, symptom resolution, and normalization of QOL in long-term UC management.
The ABTECT clinical program included the randomized, double-blind, placebo-controlled phase 3 ABTECT-1 and ABTECT-2 trials.
While surgical treatment for hemorrhoids provides better symptom relief, conservative management is safer and less invasive.
RFK Jr may remove all members of the US Preventive Services Task Force, which decides what insurers must offer at no cost to patients.
A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.